Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition Nov 07, 2019 7:30am EST
Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results Oct 29, 2019 7:30am EDT
Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call Oct 23, 2019 7:30am EDT
Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe Oct 18, 2019 7:30am EDT
Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia Sep 23, 2019 7:30am EDT
Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference Aug 28, 2019 7:30am EDT
